Istari Oncology, now with FDA clearance for PVSRIPO, raises $43.4M
Istari Oncology received FDA clearance to move forward on a Phase 1/2 clinical trial to test a drug treatment that may help treat patients with cancer.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
